1[2]Kroger N, Zeller W, Hassan HT,et al. Stem cell mobilization with G-CSF alone in breast cancer patients :higher progenitor cell yield by delivering divided doses (2 × 5μg/kg) compared to a single dose (1 × 10μg/kg). Bone Marrow Transplant, 1999 ; 23 :125 被引量：1
2[4]Olavarria E, Kanfer EJ. Selection and use of chemotherapy with hematopoietic growth factors for mobilization of peripheral blood progenitor cells.Curr Opin Hematol,2000;7(3) : 191 被引量：1
3[5]Ungkanont A, Jootar S, Chuncharunee S, et al. Delayed administration of G-CSF in both mobilization and post transplantation in autologous peripheral blood stem cell transplantation. Allergy Immunol,1999;17(4) : 289 被引量：1
4[6]Kurata H, Takakuwa K, Tsuneki I,et al. Circulating CD34+ cells to predict the adequate harvest of peripheral blood progenitor cells in platinum-based chemotherapy. Arch Gynecol Obstet, 2002 ; 266 (1) :34 被引量：1
5[7]Watts M J, Sullivan AM, Jamieson E, et al.Progenitor cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: ananalysis of progenitor cell quality yand factors predicting fo these parameters in 101pretreated with malignant lymphoma. Lin Oncol,1997;15(2): 536 被引量：1
7[9]Lee JL, Kim SB, Lee GW,et al. Clinical usefulness of the hematopoietic progenitor cell counts in predicting the optimal timing of peripheral blood stem cell harvest. Korean Med Sci, 2003 ; 18 (1) : 27 被引量：1
8[10]Lesesve JF, Lenormand B, Vannier JP. Increase of high fluorescence reticulocytes indicates mobilization of peripheral stem cells in children recovering from aplasia after chemotherapy or bone marrow transplantation. Clin Lab Haematol, 2002; 24 (5) :291 被引量：1
2Fruehauf S,Haas R,Conradt C,et al.Peripheral blood progenitor cell( PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim ( R-met HuG-CSF)-supported cytotoxic chemotherapy[].Blood.1995 被引量：1
3Hansson M,Svensson A,Engervall P,et al.Increase of monocytes predicts mobilization of peripheral stem and progenitor cells after chemotherapy followed by G-CSF administration[].European Journal of Haematology.1995 被引量：1
4Olivieri A,offidani M,Montanari M,et al.Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience[].Haematologica.1998 被引量：1
5Sandhaus LM,Edinger MG,Tubbs RR,et al.A simplified method of CD+34 cell determination for peripheral blood stem cell transplantation and correlation with clinical engraftment[].Experimental Hematology.1998 被引量：1
6Watts MJ,Sullivan AM,Jamieson E,et al.Progenitor cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor cell quality and factors predicting for these parameters in 10l pretreated with malignant lymphoma[].Journal of Clinical Oncology.1997 被引量：1
7Sutherland HJ,Eaves CJ,Lansdorp PM,et al.Kinetics of committed and primitive blood progenitor mobilization after chemotherapy and growth factor treatment and their use in autotransplants[].Blood.1994 被引量：1
8Demirer T,Buckner CD,Storner B,et al.Effect of different chemotherapy regimens on peripheral-blood stem cell collection in patients with cancer receiving granulocyte colony-stimulating factor[].Journal of Clinical Oncology.1997 被引量：1
7Kasamon YL. Blood or marrow transplantation for mantle cell lymphoma. Cure Opin Oncol,2007,19 (2) : 128-135. 被引量：1
8Roboz GJ. Treatment of acute myeloid leukemia in older patients. Expert Rev Anticancer Ther,2007,7 (3) :285-295. 被引量：1
9Koreth J, Cutler CS, Djulbegvic B, et al. High-does therapy with single autologous transplantation versus for newly diagnosed multiple myeloma:A systematic review and meta-analysis of randomized controlled trials. Bio Blood Marrow Transplant, 2007, 13 (2) :183-196. 被引量：1
